Laing R - Search Results

1

Long-term survival after low-dose-rate brachytherapy for prostate cancer: the Royal Surrey experience.

Uribe-Lewis S, Uribe J, Bourke V, Deering C, Higgins D, Mehta S, Mikropoulos C, Otter S, Perna C, Khaksar S, Laing R, Langley S. Uribe-Lewis S, et al. Among authors: laing r. BJU Int. 2022 Jun;129(6):723-730. doi: 10.1111/bju.15585. Epub 2021 Sep 22. BJU Int. 2022. PMID: 34448332

2

Prostate brachytherapy has come of age: a review of the technique and results.

Langley SE, Laing R. Langley SE, et al. Among authors: laing r. BJU Int. 2002 Feb;89(3):241-9. doi: 10.1046/j.1464-4096.2001.01610.x. BJU Int. 2002. PMID: 11856104 Review. No abstract available.

3

(125)Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics.

Henderson A, Cahill D, Laing RW, Langley SE. Henderson A, et al. Among authors: laing rw. BJU Int. 2002 Oct;90(6):567-72. doi: 10.1046/j.1464-410x.2002.02983.x. BJU Int. 2002. PMID: 12230619

4

Is bicalutamide equivalent to goserelin for prostate volume reduction before radiation therapy? A prospective, observational study.

Henderson A, Langley SE, Laing RW. Henderson A, et al. Among authors: laing rw. Clin Oncol (R Coll Radiol). 2003 Sep;15(6):318-21. doi: 10.1016/s0936-6555(03)00093-1. Clin Oncol (R Coll Radiol). 2003. PMID: 14524484 Clinical Trial.

5

The SPIRIT of research: a new well-funded randomized study comparing brachytherapy with radical prostatectomy is about to open in the UK.

Langley S, Henderson A, Laing R. Langley S, et al. Among authors: laing r. BJU Int. 2004 Jan;93(1):6-7. doi: 10.1111/j.1464-410x.2004.04545.x. BJU Int. 2004. PMID: 14678358 No abstract available.

6

Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores.

Henderson A, Laing RW, Langley SE. Henderson A, et al. Among authors: laing rw. BJU Int. 2004 Jan;93(1):180-1. doi: 10.1111/j.1464-410x.2004.t01-1-04581.x. BJU Int. 2004. PMID: 14678396 No abstract available.

7

Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A review.

Henderson A, Laing RW, Langley SE. Henderson A, et al. Eur Urol. 2004 Feb;45(2):134-41. doi: 10.1016/j.eururo.2003.09.015. Eur Urol. 2004. PMID: 14733996 Review.

8

Urinary morbidity after 125I brachytherapy of the prostate.

Henderson A, Bott SR, Sooriakumaran P, Laing RW, Langley SE. Henderson A, et al. Among authors: laing rw. BJU Int. 2004 Apr;93(6):890. doi: 10.1111/j.1464-410X.2004.4737h.x. BJU Int. 2004. PMID: 15050021 No abstract available.

9

Identification of pubic arch interference in prostate brachytherapy: simplifying the transrectal ultrasound technique.

Henderson A, Laing RW, Langley SE. Henderson A, et al. Brachytherapy. 2003;2(4):240-5. doi: 10.1016/j.brachy.2003.11.001. Brachytherapy. 2003. PMID: 15062132

10

A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy.

Henderson A, Laing RW, Langley SE. Henderson A, et al. Brachytherapy. 2002;1(4):211-8. doi: 10.1016/S1538-4721(02)00100-9. Brachytherapy. 2002. PMID: 15062169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters